ConductScience.org, home

Paper40418878

5-HT2A receptors: Pharmacology and functional selectivity.

Cummins BR and 3 others. Pharmacol Rev, 2025. Cited by 69 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. 5-HT2A receptors: Pharmacology and functional selectivity. Papers, record 40418878. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40418878

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
5-HT2A receptors: Pharmacology and functional selectivity.
PubMed
Journal
Pharmacol Rev
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
22.8, provisional
iCite
Revised in PubMed
2026-05-22
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cummins BRBenjamin R
2Billac GBGerald B
3Nichols DEDavid E
4Nichols CDCharles D

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptor, Serotonin, 5-HT2AMajor topic
Serotonin 5-HT2 Receptor AgonistsMajor topic
Humans
Animals
Hallucinogens
Serotonin 5-HT2 Receptor Antagonists
Mental Disorders

Source PubMed

References109

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138,644,550Ligand bias and inverse agonism on 5-HT2A receptor-mediated modulation of G protein activity in post-mortem human brain.Br J Pharmacol2025https://conductscience.org/library/papers/38644550PubMed
230,639,101Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex.Cell2019https://conductscience.org/library/papers/30639101PubMed
335,106,752Community guidelines for GPCR ligand bias: IUPHAR review 32.Br J Pharmacol2022https://conductscience.org/library/papers/35106752PubMed
411,069,907The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis.J Biol Chem2001https://conductscience.org/library/papers/11069907PubMed
520,198,576Association between the -1438A/G polymorphism of the serotonin 2A receptor gene and late-onset psoriasis in a Thai population.Genet Mol Res2010https://conductscience.org/library/papers/20198576PubMed
619,889,983Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19889983PubMed
731,734,018Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins.Eur Neuropsychopharmacol2019https://conductscience.org/library/papers/31734018PubMed
86,483,122Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex.Neuropharmacology1984https://conductscience.org/library/papers/6483122PubMed
927,909,165Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.J Psychopharmacol2016https://conductscience.org/library/papers/27909165PubMed
1029,898,390Psychedelics Promote Structural and Functional Neural Plasticity.Cell Rep2018https://conductscience.org/library/papers/29898390PubMed
1138,811,567G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits.Nat Commun2024https://conductscience.org/library/papers/38811567PubMed
1223,409,7245-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders.Expert Opin Investig Drugs2013https://conductscience.org/library/papers/23409724PubMed
1331,073,061Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes.Science2019https://conductscience.org/library/papers/31073061PubMed
1420,926,677Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.J Neurosci2010https://conductscience.org/library/papers/20926677PubMed
1524,567,306The evolution of the GPCR signaling system in eukaryotes: modularity, conservation, and the transition to metazoan multicellularity.Genome Biol Evol2014https://conductscience.org/library/papers/24567306PubMed
1626,841,800Psychedelics.Pharmacol Rev2016https://conductscience.org/library/papers/26841800PubMed
1717,000,863Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.Mol Pharmacol2006https://conductscience.org/library/papers/17000863PubMed
1831,243,364Conformational transitions of a neurotensin receptor 1-Gi1 complex.Nature2019https://conductscience.org/library/papers/31243364PubMed
1936,099,411Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT2A Receptor Agonists.J Med Chem2022https://conductscience.org/library/papers/36099411PubMed
2028,640,832Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice.PLoS One2017https://conductscience.org/library/papers/28640832PubMed

See all 109 references

Cited by59

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
42,964,905Therapeutic Potential of Classical Psychedelics and Non-Hallucinogenic Psychoplastogens in Psychiatric Disorders.Psychiatry Clin Psychopharmacol2026https://conductscience.org/library/papers/42964905PubMed
42,881,2245-HT2A receptors in layer 5 pyramidal neurons mediate the neuroplastic but not the hallucinogenic effects of psilocybin.Nat Neurosci2026https://conductscience.org/library/papers/42881224PubMed
42,774,867Targeting Serotonin 5-HT2A Receptors in the Treatment of Aggression: from Antipsychotics to Psychedelics.Aggress Violent Behav2026https://conductscience.org/library/papers/42774867PubMed
42,741,299Novel Tetrahydropyridinyl-6,6-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.ACS Med Chem Lett2026https://conductscience.org/library/papers/42741299PubMed
42,709,856Deconstruction of lysergic acid diethylamide.Proc Natl Acad Sci U S A2026https://conductscience.org/library/papers/42709856PubMed
42,658,346The Potential of Cannabidiol for the Treatment of Psychosis: Endocannabinoid Regulation of Serotonergic Neurotransmission via Serotonin 5-HT1A/2A Receptors.Neurochem Res2026https://conductscience.org/library/papers/42658346PubMed
42,653,771Natural Products as GPCR-Targeting Antidepressant Candidates: Advances and Opportunities.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653771PubMed
42,645,703Next-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms.CNS Drugs2026https://conductscience.org/library/papers/42645703PubMed
42,643,666Exploring the toxicity of extracts, fractions, and their bioactive components from raw and roasted sea buckthorn seeds on selected human cells.Front Mol Biosci2026https://conductscience.org/library/papers/42643666PubMed
42,621,951Novel 6,5-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.ACS Med Chem Lett2026https://conductscience.org/library/papers/42621951PubMed
42,621,425Novel Compounds as 5‑HT2A Agonists for Treating Mental Illness or CNS Disorders.ACS Med Chem Lett2026https://conductscience.org/library/papers/42621425PubMed
42,463,904Integrated 5-HT2A-TrkB and G protein signaling in serotonergic psychedelic responses.Mol Psychiatry2026https://conductscience.org/library/papers/42463904PubMed
42,445,008Novel 5,6-Bicyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.ACS Med Chem Lett2026https://conductscience.org/library/papers/42445008PubMed
42,432,011Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation.Mol Psychiatry2026https://conductscience.org/library/papers/42432011PubMed
42,305,206Novel Tricyclic Compounds as 5‑HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches.ACS Med Chem Lett2026https://conductscience.org/library/papers/42305206PubMed
42,257,400Short- and Long-Acting Psychedelics: Structure-Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics.ACS Chem Neurosci2026https://conductscience.org/library/papers/42257400PubMed
42,212,869A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects.J Psychopharmacol2026https://conductscience.org/library/papers/42212869PubMed
42,157,830Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders.ACS Med Chem Lett2026https://conductscience.org/library/papers/42157830PubMed
42,084,443Developmental and cell type-specific contributions of thalamic serotonin 2A receptors to absence seizures.Epilepsia2026https://conductscience.org/library/papers/42084443PubMed
41,993,281Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin.bioRxiv2026https://conductscience.org/library/papers/41993281PubMed

See all 59 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40418878

GET https://conductscience.org/api/papers/v1/40418878/references?page=2